SecBot SecBot

Access to Breast Cancer Diagnosis Act of 2025

H.R. 3037 Rep. Debbie Dingell (D-MI-6) In committee
Bill text PDF
  1. Introduced Apr 28
  2. Committee Apr 28
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Apr 28, 2025Next: House vote
548d ago Apr 28, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 15 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Medical Devices & Healthcare 1
Search all 2 companies, their asks and price moves Subscribe

Summary

This bill amends the Public Health Service Act to require group health plans and health insurance issuers offering group or individual coverage to cover diagnostic and supplemental breast examinations without any cost-sharing requirements, such as deductibles, coinsurance, or copayments. It also applies these requirements to grandfathered health plans and provides a safe harbor for high deductible health plans with health savings accounts.

Sec. 2, Requiring diagnostic and supplemental breast examinations to be covered with no cost-sharing: This section adds a new section 2730 to the Public Health Service Act, which prohibits group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. It defines 'cost-sharing requirements' as deductibles, coinsurance, copayments, and similar out-of-pocket expenses. 'Diagnostic breast examination' is defined as a medically necessary examination used to evaluate an abnormality from a screening or other means, including diagnostic mammography, breast MRI, or breast ultrasound. 'Supplemental breast examination' is defined as a medically necessary screening for breast cancer when no abnormality is seen, based on personal or family medical history or other risk factors. The section also allows plans to require prior authorization or other utilization controls and does not supersede state laws with greater protections.

Application to grandfathered health plans: The bill amends the Patient Protection and Affordable Care Act to apply the new requirements to grandfathered health plans.

Application to high deductible health plans with health savings account eligibility: The bill amends the Internal Revenue Code to provide a safe harbor for high deductible health plans, allowing them to cover diagnostic and supplemental breast examinations without a deductible for plan years beginning on or after January 1, 2026, without losing their status as high deductible health plans.

Effective date: The amendments apply to plan years beginning on or after January 1, 2026.

Summary of the bill text as introduced in House (Apr 28, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.